Literature DB >> 6291864

Assessment of activity in Sarcoidosis. Sensitivity and specificity of 67Gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations.

H Klech, H Kohn, F Kummer, A Mostbeck.   

Abstract

The value of different factors are examined to assess activity in 60 patients with biopsy-proven sarcoidosis. In patients with active sarcoidosis (n = 35), 67Gallium scans proved to be the most sensitive method (94 percent sensitivity), followed by serum angiotensin I converting enzyme (S-ACE) levels, chest x-ray films, and lymphocyte assays. In patients with peripheral pulmonary lesions, chest x-ray films failed in 32 percent of cases to document activity (68 percent sensitivity) whereas 67Ga scans and S-ACE levels remained to give reliable results. Despite poor specificity, negative 67Ga scans together with normal ACE levels have a high predictive value for exclusion of active sarcoidosis. In patients with peripheral pulmonary lesions, chest roentgenography is of doubtful value for staging lung involvement and assessment of activity including monitoring and control of therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291864     DOI: 10.1378/chest.82.6.732

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Thoracic imaging with gallium-67.

Authors:  H Klech; H Köhn; M Huppmann; W Pohl
Journal:  Eur J Nucl Med       Date:  1987

2.  Use of PET-CT for the assessment of treatment results in patients with sarcoidosis.

Authors:  Aysun Yakar; Fatih Yakar; Murat Sezer; Mehmet Bayram; Ezgi Başak Erdoğan; Didem Özkan; Hatice K Özçelik; Levent Tabak
Journal:  Wien Klin Wochenschr       Date:  2014-12-02       Impact factor: 1.704

3.  Relation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis.

Authors:  G M Ainslie; L W Poulter; R M du Bois
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

4.  Assessment of activity of ocular sarcoidosis by gallium scanning.

Authors:  A Karma; A A Poukkula; A O Ruokonen
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

Review 5.  18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.

Authors:  Jean Jacques Braun; Romain Kessler; André Constantinesco; Alessio Imperiale
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

6.  Testicular involvement of sarcoidosis diagnosed by gallium-67 scintigraphy.

Authors:  M A Ozguven; A C Civelek; E C Abernathy; E E Camargo
Journal:  Eur J Nucl Med       Date:  1991

7.  Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis?

Authors:  R D Cohen; P S Bunting; H O Meindok; D W Chamberlain; A S Rebuck
Journal:  Thorax       Date:  1985-07       Impact factor: 9.139

8.  18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.

Authors:  Ruth G Keijsers; Fred J Verzijlbergen; Wim J Oyen; Jules M van den Bosch; Henk J Ruven; Heleen van Velzen-Blad; Jan C Grutters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

9.  Serum ACE Level in Sarcoidosis Patients with Typical and Atypical HRCT Manifestation.

Authors:  Shahram Kahkouee; Katayoon Samadi; Ali Alai; Atefeh Abedini; Lida Rezaiian
Journal:  Pol J Radiol       Date:  2016-09-23

10.  Case report: middle-aged woman from Ghana with unsteady gait and enlarging cerebellar mass.

Authors:  Bharat Bajantri; Sindhaghatta Venkatram; Masooma Niazi; Tushi Singh; Gilda Diaz-Fuentes
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.